Latest Manufacturing News

KTEK Aerosystems has restarted deliveries under its principal production program, with an initial batch ready for collection from its European manufacturing network. The company has also lifted stated monthly manufacturing capacity to 200 units, although future revenue remains dependent on output, acceptance and logistics.

Metal Powder Works has converted its first copper infiltration order into a two-year agreement worth approximately US$600,000, adding contracted demand ahead of its planned capacity expansion. Supply is scheduled to begin in January 2027.

Firebird Metals is moving from manganese exploration towards downstream battery materials, with its Perth demonstration plant backed by a A$2 million ARENA grant. But the ASX-listed company remains loss-making, has A$3.61 million in cash and faces a material uncertainty over its ability to continue without further funding.

Rhythm Biosciences has moved ColoSTAT and geneType into commercial use, recording its first sales during FY2026. But with sales revenue of just $85,339, a $5.93 million loss and an auditor-flagged going-concern uncertainty, the next phase will be judged on cash generation and repeat adoption.

AnteoTech has received $1.905 million from the Australian R&D Tax Incentive, providing fresh cash for its battery materials and life sciences commercialisation efforts. The rebate relates to eligible research conducted during the 2026 financial year.

Green360 Technologies has moved its MKX metakaolin product from testing into commercial supply, securing a binding agreement with Holcim Australia while cutting annualised fixed cash costs by about $1.6 million. The progress comes against a $4.25 million FY2026 loss, $3.93 million in operating cash outflows and an explicit need to prove the business can scale before its cash buffer runs down.

Li-S Energy has narrowed its FY26 loss and reached several commercialisation milestones, including a 2C Power Cell, international shipping approvals and its first lithium foil sale. But the ASX battery developer still needs customer offtake and fresh funding before its proposed 1 GWh manufacturing expansion can become reality.

Pivotal Metals’ maiden scoping study gives its Horden Lake copper project a projected post-tax NPV of A$920 million against A$411 million of pre-production capital. The headline returns are strong, but the project remains a preliminary study with no Ore Reserve, material Inferred Resource exposure and more than A$400 million still to raise.

IperionX has moved its Virginia titanium operation into 24/7 production, lifting nameplate powder capacity to about 200 tonnes a year while commissioning equipment aimed at higher-value components. The progress came alongside a US$66.8 million annual loss, US$63.5 million of operating and investing cash outflows, and continued reliance on government support, customer qualification and future capital.

Firebrick Pharma has approved a phased push into US retail pharmacies after Nasodine online sales grew by more than 200% in FY26. Up to six regional pharmacy groups representing about 700 stores have expressed strong interest in early orders, although no binding orders have been disclosed.

Structural Monitoring Systems (ASX:SMN) delivered record FY26 revenue, a sharp lift in profit and $6.0 million of free cash flow as its avionics business outpaced contract manufacturing. The balance sheet is now free of bank debt, but the next leg of the story still depends on FAA approvals and converting CVM technology into commercial revenue.

EBR Systems has completed the FDA’s pre-approval inspection of its new Santa Clara manufacturing facility, receiving two Form 483 observations. The company says it expects to correct them in the fourth quarter and still anticipates approval by year-end, although the FDA has not yet made its final determination.